Medico Remedies
BSE: 540937 | NSE: MEDICO | ISIN: INE630Y01024 | SECTOR: Biotechnology & DrugsOpen
50.50High
50.80Low
48.00Prev Close
49.43P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
4.08BVolume
15.21KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
49.00
Company Description
- Biotechnology & Drugs
BSE
540937NSE
MEDICOISIN
INE630Y01024
Medico Remedies Limited is an India-based pharmaceutical formulation manufacturing company. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. It has manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. In addition, the Company also manufactures other drugs, such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Paediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others.
Company Officers
Haresh Mehta
Chairman of the Board, Legal Head and Chief Financial OfficerHarshit Mehta
Managing Director, Marketing & Export Head and Executive DirectorRishit Mehta
Production - Technical & Quality Control Head and Whole-time DirectorRita Mehta
Office Administration Head and Whole-Time DirectorGopal Jha
Administration ManagerPriyal Mehta
Marketing ManagerDushant Pandey
Quality Control ManagerDinesh Modi
Company Secretary